Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phil Hooper

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Ophthalmology (Auckland, N.Z.)|July 17, 2019
Safety of anti-VEGF treatments in a diabetic rat model and retinal cell cultureRichard Filek, Phil Hooper, Tom G Sheidow, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 16, 2019
Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patientsRichard Filek, Phil Hooper, Tom G Sheidow, et al.
Journal of Vitreoretinal Diseases|April 20, 2026
Bilateral Panuveitis and Placoid Retinitis in Ocular Syphilis Complicated by Subsequent Retinal DetachmentAmy Basilious, Khaldon F Abbas, Heather M McDonald, et al.
European Journal of Ophthalmology|August 1, 2020
The effectiveness of ocriplasmin versus surgery for the treatment of macular holes: A systematic review and meta-analysisBrian Edward Yu, Tom Sheidow, Raman-Deep Singh Sambhi, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|September 5, 2023
Treatment discontinuation patterns of anti-VEGF in retinal vein occlusionAmy Basilious, Julie Duncan, Bobbi Smuck, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|March 16, 2023
Patterns of anti-vascular endothelial growth factor discontinuation in neovascular age-related macular degenerationAmy Basilious, Bobbi Smuck, Julie Duncan, et al.
Frontiers in Cardiovascular Medicine|April 24, 2025
Use of serum long non-coding RNA expression panel as a marker for diabetic retinopathyEric Wang, Shali Chen, Anorin Ali, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Ophthalmology (Auckland, N.Z.)|July 17, 2019
Safety of anti-VEGF treatments in a diabetic rat model and retinal cell cultureRichard Filek, Phil Hooper, Tom G Sheidow, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 16, 2019
Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patientsRichard Filek, Phil Hooper, Tom G Sheidow, et al.
Journal of Vitreoretinal Diseases|April 20, 2026
Bilateral Panuveitis and Placoid Retinitis in Ocular Syphilis Complicated by Subsequent Retinal DetachmentAmy Basilious, Khaldon F Abbas, Heather M McDonald, et al.
European Journal of Ophthalmology|August 1, 2020
The effectiveness of ocriplasmin versus surgery for the treatment of macular holes: A systematic review and meta-analysisBrian Edward Yu, Tom Sheidow, Raman-Deep Singh Sambhi, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|September 5, 2023
Treatment discontinuation patterns of anti-VEGF in retinal vein occlusionAmy Basilious, Julie Duncan, Bobbi Smuck, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|March 16, 2023
Patterns of anti-vascular endothelial growth factor discontinuation in neovascular age-related macular degenerationAmy Basilious, Bobbi Smuck, Julie Duncan, et al.
Frontiers in Cardiovascular Medicine|April 24, 2025
Use of serum long non-coding RNA expression panel as a marker for diabetic retinopathyEric Wang, Shali Chen, Anorin Ali, et al.
Pageof 2